These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7023714)

  • 21. DTIC (NSC-45388) studies in the southwest oncology group.
    Costanzi JJ
    Cancer Treat Rep; 1976 Feb; 60(2):189-92. PubMed ID: 769972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination chemotherapy of malignant melanoma with imidazole carboxamide, BCNU and vincristine.
    Cohen SM; Greenspan EM; Ratner LH; Weiner MJ
    Cancer; 1977 Jan; 39(1):41-4. PubMed ID: 832250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric cancer: current status of treatment.
    Carter SK; Comis RL
    J Natl Cancer Inst; 1977 Mar; 58(3):567-78. PubMed ID: 402478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remission of uterine leiomyosarcomas treated with vincristine, Adriamycin, and dimethyl-triazeno-imidazole carboximide.
    Azizi F; Bitran J; Javehari G; Herbst AL
    Am J Obstet Gynecol; 1979 Feb; 133(4):379-81. PubMed ID: 433999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275).
    Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
    Cancer; 1982 Apr; 49(8):1555-60. PubMed ID: 7039814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
    Carter RD; Krementz ET; Hill GJ; Metter GE; Fletcher WS; Golomb FM; Grage TB; Minton JP; Sparks FC
    Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5-fluorouracil and 1-3-bis-(-2-chloroethyl)-1-nitrosourea (BCNU). Comparison with doxorubicin derivatives: 4'deoxydoxorubicin and 4'-O-methyldoxorubicin.
    Giuliani FC; Zirvi KA; Kaplan NO; Goldin A
    Int J Cancer; 1981 Jan; 27(1):5-13. PubMed ID: 7251230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of patients with refractory myelogenous leukemia with BCOMM[1,3-bis-chloro(2-chloroethyl)-1-nitrosourea (BCNU), oncovin (vincristine), cyclophosphamide, high-dose methotrexate and methyl-glyoxal bis-guanylhydrazone (MGBG)].
    Herman TS; Durie BG; Hutter JJ
    Cancer Chemother Pharmacol; 1982; 8(1):73-5. PubMed ID: 6954016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF; Eagan RT; Edmonson JH
    Cancer Chemother Rep; 1975; 59(2 Pt 1):451-3. PubMed ID: 1097102
    [No Abstract]   [Full Text] [Related]  

  • 30. [Phase II study of the water-soluble nitrosourea compound ACNU in advanced colorectal carcinomas].
    Fiebig HH; Wellens W; Peukert M; Henss H; Arnold H; Westerhausen M; Löhr GW
    Onkologie; 1984 Dec; 7(6):370-7. PubMed ID: 6396565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroblastoma in the adult: effective combination chemotherapy.
    Dosik GM; Rodriguez V; Benjamin RS; Bodey GP
    Cancer; 1978 Jan; 41(1):56-63. PubMed ID: 626943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
    Hill HZ; Hill GJ
    Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II evaluation of BCNU and 5-FU in gastrointestinal carcinomas.
    Tormey DC; Gailani S; Leone L
    Oncology; 1974; 29(3):244-8. PubMed ID: 4415043
    [No Abstract]   [Full Text] [Related]  

  • 34. Single-agent chemotherapy of brain tumors. A five-year review.
    Wilson CB; Gutin P; Boldrey EB; Drafts D; Levin VA; Enot KJ
    Arch Neurol; 1976 Nov; 33(11):739-44. PubMed ID: 185991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical studies with DTIC (NSC-45388) in various malignancies.
    Slavik M
    Cancer Treat Rep; 1976 Feb; 60(2):213-4. PubMed ID: 769976
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination therapy of solid tumors using 1,3-bis(2-chloroethyl)-1-nitrosourea (NCNU), vincristine, methotrexate, and 5-fluorouracil.
    Omura GA; Roberts GA
    Cancer; 1973 Jun; 31(6):1374-81. PubMed ID: 4709952
    [No Abstract]   [Full Text] [Related]  

  • 37. Current protocol approaches in large bowel cancer.
    Carter SK
    Semin Oncol; 1976 Dec; 3(4):433-43. PubMed ID: 793018
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancer.
    Falkson G; Pretorius HL; Falkson HC; Schoeman HS
    Cancer Chemother Pharmacol; 1983; 11(3):203-4. PubMed ID: 6416696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
    Togni P; Sessa C; Varini M; Cavalli F
    Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-Strep).
    Kemeny N; Yagoda A; Braun D; Golbey R
    Cancer; 1980 Mar; 45(5):876-81. PubMed ID: 7260839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.